BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MALT1, ENSG00000172175, 10892 AND Treatment
6 results:

  • 1. Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating malt1-NF-𝜅B-IL-6 axis of tumor-associated macrophages.
    Zhou B; Mo Z; Lai G; Chen X; Li R; Wu R; Zhu J; Zheng F
    J Exp Clin Cancer Res; 2023 Feb; 42(1):48. PubMed ID: 36797769
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. malt1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative breast cancer.
    Lee JL; Ekambaram P; Carleton NM; Hu D; Klei LR; Cai Z; Myers MI; Hubel NE; Covic L; Agnihotri S; Krappmann D; Bornancin F; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
    Mol Cancer Res; 2022 Mar; 20(3):373-386. PubMed ID: 34753803
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. malt1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.
    McAuley JR; Bailey KM; Ekambaram P; Klei LR; Kang H; Hu D; Freeman TJ; Concel VJ; Hubel NE; Lee JL; Klei HB; Cheng J; Sekar P; Bridwell RE; Covic L; Lucas PC; McAllister-Lucas LM
    Oncogene; 2019 Dec; 38(49):7384-7398. PubMed ID: 31420608
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The CARMA3-Bcl10-malt1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive breast cancer.
    Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
    Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.
    Darding M; Feltham R; Tenev T; Bianchi K; Benetatos C; Silke J; Meier P
    Cell Death Differ; 2011 Aug; 18(8):1376-86. PubMed ID: 21331077
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.
    Raderer M; Streubel B; Woehrer S; Puespoek A; Jaeger U; Formanek M; Chott A
    Clin Cancer Res; 2005 May; 11(9):3349-52. PubMed ID: 15867234
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.